ID   ECHB_HUMAN              Reviewed;         474 AA.
AC   P55084; B2RB16; B4E2W0; O14969; Q53TA6; Q96C77; Q9H3F5; Q9T2V8;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   17-OCT-2006, sequence version 3.
DT   07-APR-2021, entry version 207.
DE   RecName: Full=Trifunctional enzyme subunit beta, mitochondrial;
DE   AltName: Full=TP-beta;
DE   Includes:
DE     RecName: Full=3-ketoacyl-CoA thiolase;
DE              EC=2.3.1.155 {ECO:0000269|PubMed:7958339, ECO:0000269|PubMed:8135828, ECO:0000269|PubMed:8163672, ECO:0000269|PubMed:8651282};
DE              EC=2.3.1.16 {ECO:0000269|PubMed:1550553, ECO:0000269|PubMed:7958339, ECO:0000269|PubMed:8135828, ECO:0000269|PubMed:8163672, ECO:0000269|PubMed:8651282};
DE     AltName: Full=Acetyl-CoA acyltransferase;
DE     AltName: Full=Beta-ketothiolase;
DE   Flags: Precursor;
GN   Name=HADHB; ORFNames=MSTP029;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, CATALYTIC ACTIVITY, AND
RP   PATHWAY.
RX   PubMed=8135828; DOI=10.1006/bbrc.1994.1302;
RA   Kamijo T., Aoyama T., Komiyama A., Hashimoto T.;
RT   "Structural analysis of cDNAs for subunits of human mitochondrial fatty
RT   acid beta-oxidation trifunctional protein.";
RL   Biochem. Biophys. Res. Commun. 199:818-825(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT MTPD LYS-444.
RC   TISSUE=Blood;
RX   PubMed=9259266; DOI=10.1093/hmg/6.8.1215;
RA   Orii K.E., Aoyama T., Wakui K., Fukushima Y., Miyajima H., Yamaguchi S.,
RA   Orii T., Kondo N., Hashimoto T.;
RT   "Genomic and mutational analysis of the mitochondrial trifunctional protein
RT   beta-subunit (HADHB) gene in patients with trifunctional protein
RT   deficiency.";
RL   Hum. Mol. Genet. 6:1215-1224(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Heart;
RA   Liu B., Liu Y.Q., Wang X.Y., Zhao B., Sheng H., Zhao X.W., Liu S., Xu Y.Y.,
RA   Ye J., Song L., Gao Y., Zhang C.L., Zhang J., Wei Y.J., Cao H.Q., Zhao Y.,
RA   Liu L.S., Ding J.F., Gao R.L., Wu Q.Y., Qiang B.Q., Yuan J.G., Liew C.C.,
RA   Zhao M.S., Hui R.T.;
RL   Submitted (DEC-1998) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Stomach, and Tongue;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H., Minx P.,
RA   Wagner-McPherson C., Layman D., Wylie K., Sekhon M., Becker M.C.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Kremitzki C., Oddy L.,
RA   Du H., Sun H., Bradshaw-Cordum H., Ali J., Carter J., Cordes M., Harris A.,
RA   Isak A., van Brunt A., Nguyen C., Du F., Courtney L., Kalicki J.,
RA   Ozersky P., Abbott S., Armstrong J., Belter E.A., Caruso L., Cedroni M.,
RA   Cotton M., Davidson T., Desai A., Elliott G., Erb T., Fronick C., Gaige T.,
RA   Haakenson W., Haglund K., Holmes A., Harkins R., Kim K., Kruchowski S.S.,
RA   Strong C.M., Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N., Swearengen-Shahid S.,
RA   Snider J., Strong J.T., Thompson J., Yoakum M., Leonard S., Pearman C.,
RA   Trani L., Radionenko M., Waligorski J.E., Wang C., Rock S.M.,
RA   Tin-Wollam A.-M., Maupin R., Latreille P., Wendl M.C., Yang S.-P., Pohl C.,
RA   Wallis J.W., Spieth J., Bieri T.A., Berkowicz N., Nelson J.O., Osborne J.,
RA   Ding L., Meyer R., Sabo A., Shotland Y., Sinha P., Wohldmann P.E.,
RA   Cook L.L., Hickenbotham M.T., Eldred J., Williams D., Jones T.A., She X.,
RA   Ciccarelli F.D., Izaurralde E., Taylor J., Schmutz J., Myers R.M.,
RA   Cox D.R., Huang X., McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D., Waterston R.H.,
RA   Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2 and
RT   4.";
RL   Nature 434:724-731(2005).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT SER-209.
RC   TISSUE=Colon, Hypothalamus, Skeletal muscle, and Urinary bladder;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   PROTEIN SEQUENCE OF 34-52.
RC   TISSUE=Platelet;
RX   PubMed=12665801; DOI=10.1038/nbt810;
RA   Gevaert K., Goethals M., Martens L., Van Damme J., Staes A., Thomas G.R.,
RA   Vandekerckhove J.;
RT   "Exploring proteomes and analyzing protein processing by mass spectrometric
RT   identification of sorted N-terminal peptides.";
RL   Nat. Biotechnol. 21:566-569(2003).
RN   [8]
RP   PROTEIN SEQUENCE OF 48-63, AND CATALYTIC ACTIVITY.
RC   TISSUE=Liver;
RX   PubMed=7958339; DOI=10.1042/bst0220427;
RA   Middleton B.;
RT   "The mitochondrial long-chain trifunctional enzyme: 2-enoyl-CoA hydratase,
RT   3-hydroxyacyl-CoA dehydrogenase and 3-oxoacyl-CoA thiolase.";
RL   Biochem. Soc. Trans. 22:427-431(1994).
RN   [9]
RP   PROTEIN SEQUENCE OF 62-72 AND 96-111.
RC   TISSUE=Adipocyte;
RX   PubMed=15242332; DOI=10.1042/bj20040647;
RA   Aboulaich N., Vainonen J.P., Stralfors P., Vener A.V.;
RT   "Vectorial proteomics reveal targeting, phosphorylation and specific
RT   fragmentation of polymerase I and transcript release factor (PTRF) at the
RT   surface of caveolae in human adipocytes.";
RL   Biochem. J. 383:237-248(2004).
RN   [10]
RP   CATALYTIC ACTIVITY.
RX   PubMed=1550553; DOI=10.1016/0006-291x(92)90501-b;
RA   Carpenter K., Pollitt R.J., Middleton B.;
RT   "Human liver long-chain 3-hydroxyacyl-coenzyme A dehydrogenase is a
RT   multifunctional membrane-bound beta-oxidation enzyme of mitochondria.";
RL   Biochem. Biophys. Res. Commun. 183:443-448(1992).
RN   [11]
RP   CATALYTIC ACTIVITY, AND SUBUNIT.
RX   PubMed=8163672; DOI=10.1172/jci117158;
RA   Kamijo T., Wanders R.J., Saudubray J.-M., Aoyama T., Komiyama A.,
RA   Hashimoto T.;
RT   "Mitochondrial trifunctional protein deficiency. Catalytic heterogeneity of
RT   the mutant enzyme in two patients.";
RL   J. Clin. Invest. 93:1740-1747(1994).
RN   [12]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-72 AND LYS-188, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C.,
RA   Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY, SUBCELLULAR LOCATION, AND INTERACTION
RP   WITH RSAD2.
RX   PubMed=21527675; DOI=10.1126/science.1202007;
RA   Seo J.Y., Yaneva R., Hinson E.R., Cresswell P.;
RT   "Human cytomegalovirus directly induces the antiviral protein viperin to
RT   enhance infectivity.";
RL   Science 332:1093-1097(2011).
RN   [15]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [16]
RP   CLEAVAGE OF TRANSIT PEPTIDE [LARGE SCALE ANALYSIS] AFTER ARG-33, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [17]
RP   STRUCTURE BY ELECTRON MICROSCOPY (4.20 ANGSTROMS), FUNCTION, SUBUNIT,
RP   SUBCELLULAR LOCATION, AND TOPOLOGY.
RX   PubMed=29915090; DOI=10.1073/pnas.1801252115;
RA   Liang K., Li N., Wang X., Dai J., Liu P., Wang C., Chen X.W., Gao N.,
RA   Xiao J.;
RT   "Cryo-EM structure of human mitochondrial trifunctional protein.";
RL   Proc. Natl. Acad. Sci. U.S.A. 115:7039-7044(2018).
RN   [18]
RP   X-RAY CRYSTALLOGRAPHY (3.60 ANGSTROMS) OF 34-474, FUNCTION, SUBUNIT, AND
RP   ACTIVE SITE.
RX   PubMed=30850536; DOI=10.1073/pnas.1816317116;
RA   Xia C., Fu Z., Battaile K.P., Kim J.P.;
RT   "Crystal structure of human mitochondrial trifunctional protein, a fatty
RT   acid beta-oxidation metabolon.";
RL   Proc. Natl. Acad. Sci. U.S.A. 116:6069-6074(2019).
RN   [19]
RP   VARIANTS MTPD HIS-61; HIS-247 AND GLY-263, AND CATALYTIC ACTIVITY.
RX   PubMed=8651282;
RA   Ushikubo S., Aoyama T., Kamijo T., Wanders R.J.A., Rinaldo P., Vockley J.,
RA   Hashimoto T.;
RT   "Molecular characterization of mitochondrial trifunctional protein
RT   deficiency: formation of the enzyme complex is important for stabilization
RT   of both alpha- and beta-subunits.";
RL   Am. J. Hum. Genet. 58:979-988(1996).
RN   [20]
RP   VARIANTS MTPD ASP-59; CYS-61; HIS-61; GLY-117; PRO-121; PRO-133; GLY-242;
RP   HIS-247; 259-GLY--PRO-270 DEL; GLY-263; ASP-280; ARG-294; LEU-294; SER-301
RP   AND LYS-444.
RX   PubMed=12754706; DOI=10.1002/humu.10211;
RA   Spiekerkoetter U., Sun B., Khuchua Z., Bennett M.J., Strauss A.W.;
RT   "Molecular and phenotypic heterogeneity in mitochondrial trifunctional
RT   protein deficiency due to beta-subunit mutations.";
RL   Hum. Mutat. 21:598-607(2003).
RN   [21]
RP   VARIANT [LARGE SCALE ANALYSIS] VAL-119.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S., Buckhaults P.,
RA   Farrell C., Meeh P., Markowitz S.D., Willis J., Dawson D., Willson J.K.V.,
RA   Gazdar A.F., Hartigan J., Wu L., Liu C., Parmigiani G., Park B.H.,
RA   Bachman K.E., Papadopoulos N., Vogelstein B., Kinzler K.W.,
RA   Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal cancers.";
RL   Science 314:268-274(2006).
CC   -!- FUNCTION: Mitochondrial trifunctional enzyme catalyzes the last three
CC       of the four reactions of the mitochondrial beta-oxidation pathway
CC       (PubMed:8135828, PubMed:29915090, PubMed:30850536). The mitochondrial
CC       beta-oxidation pathway is the major energy-producing process in tissues
CC       and is performed through four consecutive reactions breaking down fatty
CC       acids into acetyl-CoA (PubMed:29915090). Among the enzymes involved in
CC       this pathway, the trifunctional enzyme exhibits specificity for long-
CC       chain fatty acids (PubMed:30850536). Mitochondrial trifunctional enzyme
CC       is a heterotetrameric complex composed of two proteins, the
CC       trifunctional enzyme subunit alpha/HADHA carries the 2,3-enoyl-CoA
CC       hydratase and the 3-hydroxyacyl-CoA dehydrogenase activities, while the
CC       trifunctional enzyme subunit beta/HADHB described here bears the 3-
CC       ketoacyl-CoA thiolase activity (PubMed:8135828, PubMed:29915090,
CC       PubMed:30850536). {ECO:0000269|PubMed:29915090,
CC       ECO:0000269|PubMed:30850536, ECO:0000269|PubMed:8135828,
CC       ECO:0000303|PubMed:29915090, ECO:0000303|PubMed:30850536}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=acetyl-CoA + an acyl-CoA = a 3-oxoacyl-CoA + CoA;
CC         Xref=Rhea:RHEA:21564, ChEBI:CHEBI:57287, ChEBI:CHEBI:57288,
CC         ChEBI:CHEBI:58342, ChEBI:CHEBI:90726; EC=2.3.1.16;
CC         Evidence={ECO:0000269|PubMed:7958339, ECO:0000269|PubMed:8135828,
CC         ECO:0000269|PubMed:8163672, ECO:0000269|PubMed:8651282};
CC       PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:21566;
CC         Evidence={ECO:0000269|PubMed:8135828};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=acetyl-CoA + butanoyl-CoA = 3-oxohexanoyl-CoA + CoA;
CC         Xref=Rhea:RHEA:31111, ChEBI:CHEBI:57287, ChEBI:CHEBI:57288,
CC         ChEBI:CHEBI:57371, ChEBI:CHEBI:62418;
CC         Evidence={ECO:0000269|PubMed:1550553};
CC       PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:31113;
CC         Evidence={ECO:0000269|PubMed:8135828};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=acetyl-CoA + hexanoyl-CoA = 3-oxooctanoyl-CoA + CoA;
CC         Xref=Rhea:RHEA:31203, ChEBI:CHEBI:57287, ChEBI:CHEBI:57288,
CC         ChEBI:CHEBI:62619, ChEBI:CHEBI:62620;
CC         Evidence={ECO:0000269|PubMed:8163672};
CC       PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:31205;
CC         Evidence={ECO:0000269|PubMed:8135828};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=acetyl-CoA + octanoyl-CoA = 3-oxodecanoyl-CoA + CoA;
CC         Xref=Rhea:RHEA:31087, ChEBI:CHEBI:57287, ChEBI:CHEBI:57288,
CC         ChEBI:CHEBI:57386, ChEBI:CHEBI:62548;
CC         Evidence={ECO:0000269|PubMed:1550553};
CC       PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:31089;
CC         Evidence={ECO:0000269|PubMed:8135828};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=acetyl-CoA + decanoyl-CoA = 3-oxododecanoyl-CoA + CoA;
CC         Xref=Rhea:RHEA:31183, ChEBI:CHEBI:57287, ChEBI:CHEBI:57288,
CC         ChEBI:CHEBI:61430, ChEBI:CHEBI:62615;
CC         Evidence={ECO:0000269|PubMed:8163672};
CC       PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:31185;
CC         Evidence={ECO:0000269|PubMed:8135828};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=acetyl-CoA + dodecanoyl-CoA = 3-oxotetradecanoyl-CoA + CoA;
CC         Xref=Rhea:RHEA:31091, ChEBI:CHEBI:57287, ChEBI:CHEBI:57288,
CC         ChEBI:CHEBI:57375, ChEBI:CHEBI:62543;
CC         Evidence={ECO:0000269|PubMed:1550553};
CC       PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:31093;
CC         Evidence={ECO:0000269|PubMed:8135828};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=acetyl-CoA + tetradecanoyl-CoA = 3-oxohexadecanoyl-CoA + CoA;
CC         Xref=Rhea:RHEA:18161, ChEBI:CHEBI:57287, ChEBI:CHEBI:57288,
CC         ChEBI:CHEBI:57349, ChEBI:CHEBI:57385; EC=2.3.1.155;
CC         Evidence={ECO:0000269|PubMed:1550553, ECO:0000269|PubMed:7958339,
CC         ECO:0000269|PubMed:8135828, ECO:0000269|PubMed:8163672,
CC         ECO:0000269|PubMed:8651282};
CC       PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:18163;
CC         Evidence={ECO:0000269|PubMed:8135828};
CC   -!- PATHWAY: Lipid metabolism; fatty acid beta-oxidation.
CC       {ECO:0000269|PubMed:8135828}.
CC   -!- SUBUNIT: Heterotetramer of 2 alpha/HADHA and 2 beta/HADHB subunits;
CC       forms the mitochondrial trifunctional enzyme (PubMed:29915090,
CC       PubMed:30850536). Also purified as higher order heterooligomers
CC       including a 4 alpha/HADHA and 4 beta/HADHB heterooligomer which
CC       physiological significance remains unclear (PubMed:8163672,
CC       PubMed:29915090). Interacts with RSAD2/viperin (PubMed:21527675).
CC       {ECO:0000269|PubMed:21527675, ECO:0000269|PubMed:29915090,
CC       ECO:0000269|PubMed:30850536, ECO:0000269|PubMed:8163672}.
CC   -!- INTERACTION:
CC       P55084; Q9H0R8: GABARAPL1; NbExp=4; IntAct=EBI-356635, EBI-746969;
CC       P55084; P40939: HADHA; NbExp=4; IntAct=EBI-356635, EBI-356720;
CC   -!- SUBCELLULAR LOCATION: Mitochondrion {ECO:0000269|PubMed:21527675}.
CC       Mitochondrion inner membrane {ECO:0000269|PubMed:21527675}.
CC       Mitochondrion outer membrane {ECO:0000269|PubMed:21527675}. Endoplasmic
CC       reticulum {ECO:0000269|PubMed:21527675}. Note=Protein stability and
CC       association with membranes require HADHA.
CC       {ECO:0000269|PubMed:29915090}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P55084-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P55084-2; Sequence=VSP_054426;
CC   -!- DISEASE: Mitochondrial trifunctional protein deficiency (MTPD)
CC       [MIM:609015]: A disease biochemically characterized by loss of all
CC       enzyme activities of the mitochondrial trifunctional protein complex.
CC       Variable clinical manifestations include hypoglycemia, cardiomyopathy,
CC       delayed psychomotor development, sensorimotor axonopathy, generalized
CC       weakness, hepatic dysfunction, respiratory failure. Sudden infant death
CC       may occur. Most patients die from heart failure.
CC       {ECO:0000269|PubMed:12754706, ECO:0000269|PubMed:8651282,
CC       ECO:0000269|PubMed:9259266}. Note=The disease is caused by variants
CC       affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the thiolase-like superfamily. Thiolase family.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA22061.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; D16481; BAA03942.1; -; mRNA.
DR   EMBL; D86850; BAA22061.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; AF113209; AAG39280.1; -; mRNA.
DR   EMBL; AK304455; BAG65272.1; -; mRNA.
DR   EMBL; AK314455; BAG37063.1; -; mRNA.
DR   EMBL; AC010896; AAY14644.1; -; Genomic_DNA.
DR   EMBL; BC014572; AAH14572.1; -; mRNA.
DR   EMBL; BC017564; AAH17564.1; -; mRNA.
DR   EMBL; BC030824; AAH30824.1; -; mRNA.
DR   EMBL; BC066963; AAH66963.1; -; mRNA.
DR   CCDS; CCDS1722.1; -. [P55084-1]
DR   CCDS; CCDS62872.1; -. [P55084-2]
DR   PIR; JC2109; JC2109.
DR   RefSeq; NP_000174.1; NM_000183.2. [P55084-1]
DR   RefSeq; NP_001268441.1; NM_001281512.1.
DR   RefSeq; NP_001268442.1; NM_001281513.1. [P55084-2]
DR   RefSeq; XP_011531105.1; XM_011532803.1. [P55084-1]
DR   PDB; 5ZQZ; EM; 4.20 A; B/D=1-474.
DR   PDB; 5ZRV; EM; 7.70 A; B/D/F/H=1-474.
DR   PDB; 6DV2; X-ray; 3.60 A; A/B/C/D/E/F=34-474.
DR   PDBsum; 5ZQZ; -.
DR   PDBsum; 5ZRV; -.
DR   PDBsum; 6DV2; -.
DR   SMR; P55084; -.
DR   BioGRID; 109282; 305.
DR   ComplexPortal; CPX-6245; Mitochondrial trifunctional enzyme complex.
DR   CORUM; P55084; -.
DR   IntAct; P55084; 103.
DR   MINT; P55084; -.
DR   STRING; 9606.ENSP00000325136; -.
DR   MoonProt; P55084; -.
DR   iPTMnet; P55084; -.
DR   MetOSite; P55084; -.
DR   PhosphoSitePlus; P55084; -.
DR   SwissPalm; P55084; -.
DR   BioMuta; HADHB; -.
DR   DMDM; 116241345; -.
DR   UCD-2DPAGE; P55084; -.
DR   EPD; P55084; -.
DR   jPOST; P55084; -.
DR   MassIVE; P55084; -.
DR   MaxQB; P55084; -.
DR   PaxDb; P55084; -.
DR   PeptideAtlas; P55084; -.
DR   PRIDE; P55084; -.
DR   ProteomicsDB; 56786; -. [P55084-1]
DR   ProteomicsDB; 5856; -.
DR   Antibodypedia; 27848; 234 antibodies.
DR   DNASU; 3032; -.
DR   Ensembl; ENST00000317799; ENSP00000325136; ENSG00000138029. [P55084-1]
DR   Ensembl; ENST00000545822; ENSP00000442665; ENSG00000138029. [P55084-2]
DR   GeneID; 3032; -.
DR   KEGG; hsa:3032; -.
DR   UCSC; uc002rgz.4; human. [P55084-1]
DR   CTD; 3032; -.
DR   DisGeNET; 3032; -.
DR   GeneCards; HADHB; -.
DR   HGNC; HGNC:4803; HADHB.
DR   HPA; ENSG00000138029; Tissue enhanced (heart muscle, skeletal muscle).
DR   MalaCards; HADHB; -.
DR   MIM; 143450; gene.
DR   MIM; 609015; phenotype.
DR   neXtProt; NX_P55084; -.
DR   OpenTargets; ENSG00000138029; -.
DR   Orphanet; 746; Mitochondrial trifunctional protein deficiency.
DR   PharmGKB; PA29177; -.
DR   VEuPathDB; HostDB:ENSG00000138029.13; -.
DR   eggNOG; KOG1392; Eukaryota.
DR   GeneTree; ENSGT01020000230542; -.
DR   InParanoid; P55084; -.
DR   OMA; MTAFPEP; -.
DR   OrthoDB; 1129049at2759; -.
DR   PhylomeDB; P55084; -.
DR   TreeFam; TF315243; -.
DR   BioCyc; MetaCyc:HS06436-MONOMER; -.
DR   PathwayCommons; P55084; -.
DR   Reactome; R-HSA-1482798; Acyl chain remodeling of CL.
DR   Reactome; R-HSA-77285; Beta oxidation of myristoyl-CoA to lauroyl-CoA.
DR   Reactome; R-HSA-77288; mitochondrial fatty acid beta-oxidation of unsaturated fatty acids.
DR   Reactome; R-HSA-77305; Beta oxidation of palmitoyl-CoA to myristoyl-CoA.
DR   Reactome; R-HSA-77310; Beta oxidation of lauroyl-CoA to decanoyl-CoA-CoA.
DR   Reactome; R-HSA-77346; Beta oxidation of decanoyl-CoA to octanoyl-CoA-CoA.
DR   Reactome; R-HSA-77348; Beta oxidation of octanoyl-CoA to hexanoyl-CoA.
DR   Reactome; R-HSA-77350; Beta oxidation of hexanoyl-CoA to butanoyl-CoA.
DR   UniPathway; UPA00659; -.
DR   BioGRID-ORCS; 3032; 4 hits in 994 CRISPR screens.
DR   ChiTaRS; HADHB; human.
DR   GeneWiki; HADHB; -.
DR   GenomeRNAi; 3032; -.
DR   Pharos; P55084; Tbio.
DR   PRO; PR:P55084; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   RNAct; P55084; protein.
DR   Bgee; ENSG00000138029; Expressed in heart right ventricle and 248 other tissues.
DR   ExpressionAtlas; P55084; baseline and differential.
DR   Genevisible; P55084; HS.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:UniProtKB.
DR   GO; GO:0005740; C:mitochondrial envelope; TAS:ProtInc.
DR   GO; GO:0005743; C:mitochondrial inner membrane; IDA:UniProtKB.
DR   GO; GO:0042645; C:mitochondrial nucleoid; IDA:BHF-UCL.
DR   GO; GO:0005741; C:mitochondrial outer membrane; IDA:UniProtKB.
DR   GO; GO:0005739; C:mitochondrion; IDA:HPA.
DR   GO; GO:0003857; F:3-hydroxyacyl-CoA dehydrogenase activity; TAS:ProtInc.
DR   GO; GO:0003988; F:acetyl-CoA C-acyltransferase activity; TAS:ProtInc.
DR   GO; GO:0050633; F:acetyl-CoA C-myristoyltransferase activity; IEA:UniProtKB-EC.
DR   GO; GO:0004300; F:enoyl-CoA hydratase activity; TAS:ProtInc.
DR   GO; GO:0003723; F:RNA binding; HDA:UniProtKB.
DR   GO; GO:0035965; P:cardiolipin acyl-chain remodeling; TAS:Reactome.
DR   GO; GO:0006635; P:fatty acid beta-oxidation; IBA:GO_Central.
DR   CDD; cd00751; thiolase; 1.
DR   Gene3D; 3.40.47.10; -; 1.
DR   InterPro; IPR002155; Thiolase.
DR   InterPro; IPR016039; Thiolase-like.
DR   InterPro; IPR020615; Thiolase_acyl_enz_int_AS.
DR   InterPro; IPR020610; Thiolase_AS.
DR   InterPro; IPR020617; Thiolase_C.
DR   InterPro; IPR020613; Thiolase_CS.
DR   InterPro; IPR020616; Thiolase_N.
DR   Pfam; PF02803; Thiolase_C; 1.
DR   Pfam; PF00108; Thiolase_N; 1.
DR   SUPFAM; SSF53901; SSF53901; 2.
DR   TIGRFAMs; TIGR01930; AcCoA-C-Actrans; 1.
DR   PROSITE; PS00098; THIOLASE_1; 1.
DR   PROSITE; PS00737; THIOLASE_2; 1.
DR   PROSITE; PS00099; THIOLASE_3; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Acyltransferase; Alternative splicing;
KW   Direct protein sequencing; Disease variant; Endoplasmic reticulum;
KW   Fatty acid metabolism; Lipid metabolism; Membrane; Mitochondrion;
KW   Mitochondrion inner membrane; Mitochondrion outer membrane;
KW   Reference proteome; Transferase; Transit peptide.
FT   TRANSIT         1..33
FT                   /note="Mitochondrion"
FT                   /evidence="ECO:0000269|PubMed:12665801,
FT                   ECO:0007744|PubMed:25944712"
FT   CHAIN           34..474
FT                   /note="Trifunctional enzyme subunit beta, mitochondrial"
FT                   /id="PRO_0000034080"
FT   INTRAMEM        173..220
FT                   /evidence="ECO:0000305|PubMed:29915090"
FT   ACT_SITE        138
FT                   /note="Acyl-thioester intermediate"
FT                   /evidence="ECO:0000305|PubMed:30850536"
FT   ACT_SITE        458
FT                   /note="Proton donor/acceptor"
FT                   /evidence="ECO:0000305|PubMed:30850536"
FT   SITE            428
FT                   /note="Increases nucleophilicity of active site Cys"
FT                   /evidence="ECO:0000305|PubMed:30850536"
FT   MOD_RES         72
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0007744|PubMed:19608861"
FT   MOD_RES         72
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q99JY0"
FT   MOD_RES         188
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0007744|PubMed:19608861"
FT   MOD_RES         188
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q99JY0"
FT   MOD_RES         190
FT                   /note="N6-succinyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q99JY0"
FT   MOD_RES         272
FT                   /note="N6-succinyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q99JY0"
FT   MOD_RES         291
FT                   /note="N6-succinyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q99JY0"
FT   MOD_RES         293
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q99JY0"
FT   MOD_RES         293
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q99JY0"
FT   MOD_RES         298
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q99JY0"
FT   MOD_RES         332
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q99JY0"
FT   MOD_RES         332
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q99JY0"
FT   MOD_RES         348
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q99JY0"
FT   MOD_RES         361
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q99JY0"
FT   VAR_SEQ         1..36
FT                   /note="MTILTYPFKNLPTASKWALRFSIRPLSCSSQLRAAP -> MTLVSGWLLYGW
FT                   II (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_054426"
FT   VARIANT         59
FT                   /note="G -> D (in MTPD)"
FT                   /evidence="ECO:0000269|PubMed:12754706"
FT                   /id="VAR_021128"
FT   VARIANT         61
FT                   /note="R -> C (in MTPD; dbSNP:rs780351691)"
FT                   /evidence="ECO:0000269|PubMed:12754706"
FT                   /id="VAR_021129"
FT   VARIANT         61
FT                   /note="R -> H (in MTPD; dbSNP:rs121913132)"
FT                   /evidence="ECO:0000269|PubMed:12754706,
FT                   ECO:0000269|PubMed:8651282"
FT                   /id="VAR_007493"
FT   VARIANT         117
FT                   /note="R -> G (in MTPD)"
FT                   /evidence="ECO:0000269|PubMed:12754706"
FT                   /id="VAR_021130"
FT   VARIANT         119
FT                   /note="A -> V (in a breast cancer sample; somatic
FT                   mutation)"
FT                   /evidence="ECO:0000269|PubMed:16959974"
FT                   /id="VAR_035705"
FT   VARIANT         121
FT                   /note="L -> P (in MTPD; dbSNP:rs773127211)"
FT                   /evidence="ECO:0000269|PubMed:12754706"
FT                   /id="VAR_021131"
FT   VARIANT         133
FT                   /note="T -> P (in MTPD; dbSNP:rs371159065)"
FT                   /evidence="ECO:0000269|PubMed:12754706"
FT                   /id="VAR_021132"
FT   VARIANT         209
FT                   /note="P -> S (in dbSNP:rs17851200)"
FT                   /evidence="ECO:0000269|PubMed:15489334"
FT                   /id="VAR_028231"
FT   VARIANT         242
FT                   /note="D -> G (in MTPD; dbSNP:rs1166120479)"
FT                   /evidence="ECO:0000269|PubMed:12754706"
FT                   /id="VAR_021133"
FT   VARIANT         247
FT                   /note="R -> H (in MTPD; dbSNP:rs121913133)"
FT                   /evidence="ECO:0000269|PubMed:12754706,
FT                   ECO:0000269|PubMed:8651282"
FT                   /id="VAR_007494"
FT   VARIANT         259..270
FT                   /note="Missing (in MTPD)"
FT                   /evidence="ECO:0000269|PubMed:12754706"
FT                   /id="VAR_021134"
FT   VARIANT         263
FT                   /note="D -> G (in MTPD; dbSNP:rs121913131)"
FT                   /evidence="ECO:0000269|PubMed:12754706,
FT                   ECO:0000269|PubMed:8651282"
FT                   /id="VAR_007495"
FT   VARIANT         277
FT                   /note="K -> R (in dbSNP:rs57969630)"
FT                   /id="VAR_061897"
FT   VARIANT         280
FT                   /note="G -> D (in MTPD; dbSNP:rs751772298)"
FT                   /evidence="ECO:0000269|PubMed:12754706"
FT                   /id="VAR_021135"
FT   VARIANT         294
FT                   /note="P -> L (in MTPD)"
FT                   /evidence="ECO:0000269|PubMed:12754706"
FT                   /id="VAR_021136"
FT   VARIANT         294
FT                   /note="P -> R (in MTPD; dbSNP:rs1558357879)"
FT                   /evidence="ECO:0000269|PubMed:12754706"
FT                   /id="VAR_021137"
FT   VARIANT         301
FT                   /note="G -> S (in MTPD; dbSNP:rs891954464)"
FT                   /evidence="ECO:0000269|PubMed:12754706"
FT                   /id="VAR_021138"
FT   VARIANT         444
FT                   /note="R -> K (in MTPD; dbSNP:rs121913134)"
FT                   /evidence="ECO:0000269|PubMed:12754706,
FT                   ECO:0000269|PubMed:9259266"
FT                   /id="VAR_017409"
FT   CONFLICT        1
FT                   /note="M -> MT (in Ref. 3; AAG39280 and 6; AAH14572/
FT                   AAH17564/AAH30824/AAH66963)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   474 AA;  51294 MW;  A7B41C37BEC1E6AD CRC64;
     MTILTYPFKN LPTASKWALR FSIRPLSCSS QLRAAPAVQT KTKKTLAKPN IRNVVVVDGV
     RTPFLLSGTS YKDLMPHDLA RAALTGLLHR TSVPKEVVDY IIFGTVIQEV KTSNVAREAA
     LGAGFSDKTP AHTVTMACIS ANQAMTTGVG LIASGQCDVI VAGGVELMSD VPIRHSRKMR
     KLMLDLNKAK SMGQRLSLIS KFRFNFLAPE LPAVSEFSTS ETMGHSADRL AAAFAVSRLE
     QDEYALRSHS LAKKAQDEGL LSDVVPFKVP GKDTVTKDNG IRPSSLEQMA KLKPAFIKPY
     GTVTAANSSF LTDGASAMLI MAEEKALAMG YKPKAYLRDF MYVSQDPKDQ LLLGPTYATP
     KVLEKAGLTM NDIDAFEFHE AFSGQILANF KAMDSDWFAE NYMGRKTKVG LPPLEKFNNW
     GGSLSLGHPF GATGCRLVMA AANRLRKEGG QYGLVAACAA GGQGHAMIVE AYPK
//
